bioRxivCell Biology
TRPML1 activation ameliorates lysosomal phenotypes in CLN3 deficient retinal pigment epithelial cells
D. Wuenkhaus, R. Tang, K. Nyame, N. N. Laqtom, M. Schweizer, A. S. Rosato, E. K. Kroegsaeter, C. Wollnik, M. Abu-Remaileh, C. Grimm, G. Hermey, R. Kuhn, D. Gruber-Schoffnegger, S. Markmann
Abstract
Mutations in the lysosomal membrane protein CLN3 cause Juvenile Neuronal Ceroid Lipofuscinosis (JNCL). Activation of the lysosomal ion channel TRPML1 has previously been shown to be beneficial in several neurodegenerative disease models. Here, we tested whether TRPML1 activation rescues disease-associated phenotypes in CLN3-deficient retinal pigment epithelial (ARPE-19 CLN3-KO) cells. ARPE-19 CLN3-KO cells accumulate LAMP1 positive organelles and show lysosomal storage of mitochondrial ATPase subunit C (SubC), globotriaosylceramide (Gb3), and glycerophosphodiesters (GPDs), whereas lysosomal bis(monoacylglycero)phosphate (BMP/LBPA) lipid levels were significantly decreased. Activation of TRPML1 reduced lysosomal storage of Gb3 and SubC but failed to restore BMP levels in CLN3-KO cells. TRPML1-mediated decrease of storage was TFEB-independent, and we identified TRPML1-mediated enhanced lysosomal exocytosis as a likely mechanism for clearing storage including GPDs. Therefore, ARPE-19 CLN3-KO cells represent a human cell model for CLN3 disease showing many of the described core lysosomal deficits, some of which can be improved using TRPML1 agonists.
- organism: human
- assay: proteomics
- assay: metabolomics
- research focus: cell type annotation
- research focus: differential expression
- research focus: cell signaling & trafficking
- research focus: chromatin & epigenetic regulation
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Genetic and cellular basis of impaired phagocytosis and photoreceptor degeneration in CLN3 disease.
Jimin Han, Sueanne Chear, … Ruchira Singh·Investigative Ophthalmology & Visual SciencePeer-reviewed·Nov 13, 2024
- Lysosomal alterations and decreased electrophysiological activity in CLN3 disease (966 bp deletion, E295K) patient-derived cortical neurons
Sueanne Chear, Sharn E. Perry, … Anthony L Cook·Disease Models & MechanismsPeer-reviewed·Dec 1, 2022
- CLN3 regulates endosomal function by modulating Rab7A activity
S. Yasa, G. Modica, … S. Lefrancois·bioRxiv·May 10, 2019
- A 3D iPSC retina model reveals non-cell-autonomous and non-neuronal mechanism of photoreceptor degeneration in a lysosomal storage disorder.
Jimin Han, Nathaniel Foley, … Ruchira Singh·bioRxiv·Jul 10, 2025
- Cellular Modeling of CLN6 with IPSC-derived Neurons and Glia
María Gabriela Otero, Jaemin Kim, … Tyler Mark Pierson·bioRxiv·Jan 29, 2024
- CLN3 deficiency leads to neurological and metabolic perturbations during early development
Ursula Heins-Marroquin, Randolph R. Singh, … Carole L. Linster·Life Science AlliancePeer-reviewed·Jan 9, 2024